Phase I-II

Sanofi extends its RWD-focused partnership with Evidation

10-Jan-2022 By Jenni Spinner

The collaboration will center on development of unique data sets, which could be used in helping promote better understanding of aspects of human health.

Stand Up To Cancer research initiative targets pancreatic cancer

10-Jan-2022 By Jenni Spinner

Joining with a noted research foundation, the group is aiming for earlier detection and treatment of the disease, which hits nearly 500K people annually.

People on the Move: January 2022

06-Jan-2022 By Jenni Spinner

This month’s news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

Artificial intelligence could benefit all aspects of clinical trials: IQVIA

04-Jan-2022 By Jenni Spinner

An AI expert discusses progress in the field, gaps in understanding, and how predictive modeling and other advanced analytical tools could be put to use.

Road ahead paved with innovation, opportunities: Syneos Health

04-Jan-2022 By Jenni Spinner

A forward-looking report from company experts includes a breakdown of the top trends to watch for in pharmaceutical development and in healthcare overall.

Lessons learned can help advance the future of DCTs: ObvioHealth

03-Jan-2022 By Jenni Spinner

A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.

Dogs, VR, and rock stars: OSP’s favorite items of 2021

22-Dec-2021 By Jenni Spinner

It has been a pleasure for the OSP team to connect with a long list of fascinating industry minds and share the stories; here are a few of our favorites.

Purchases, pandemic, and potential treatments: 2021’s greatest hits

22-Dec-2021 By Jenni Spinner

OSP’s list of the year’s most-read stories shows readers are interested in M&A activities, new drug candidates, COVID-19 developments, and other hot news.

Time to put patient voice first in cancer research: GRYT Health

21-Dec-2021 By Jenni Spinner

The organization is working to give oncology professionals the chance to hear directly from patients about their unique experiences, concerns, and hopes.

Industry united in 2021 to battle significant adversity: Oracle

21-Dec-2021 By Jenni Spinner

A leader from Oracle Health Sciences shares insights on how drug development and research pros collaborated to overcome formidable challenges this year.

Tech Innovations: December 2021

21-Dec-2021 By Jenni Spinner

This month’s collaborations, tech partnerships, new facilities, and other happenings includes news from Flywheel, Medable, Veeva, and other organizations.

2021 year-end wrapup

Industry insights: obstacles, positives, and looking ahead

16-Dec-2021 By Jenni Spinner

Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.

2021 year-end wrapup

Signant Health: consider DCT design factors from the start

16-Dec-2021 By Jenni Spinner

While the pandemic saw many trials to shift to decentralized midstream, an expert from the trial tech firm suggests a ground-up design approach is preferable.

2021 year-end wrapup

Technology ‘culture of adoption’ vital for industry future: DTRA

16-Dec-2021 By Jenni Spinner

A leader from the Decentralized Trials and Research Alliance offers perspective on the tools, technology, and thinking needed to advance clinical research.

Michael J. Fox Foundation significantly expands Parkinson’s study

15-Dec-2021 By Jenni Spinner

The Parkinson’s Progression Markers Initiative, built using Evidation Health’s research platform, aims to triple enrollment and recruit online participants.

Insilico Medicine launches trial for AI-discovered drug

15-Dec-2021 By Jenni Spinner

The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis.

Pfizer shares more promising results from COVID-19 study

14-Dec-2021 By Jenni Spinner

According to the company, the latest Phase II/III study results show its novel oral treatment candidate is effective in reducing hospitalizations and deaths.

Abbott, Howard University join to boost research diversity

13-Dec-2021 By Jenni Spinner

The healthcare company has gifted $1m to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing diversity.

Pfizer buys immuno-inflammatory firm Arena Pharmaceuticals for $6.7b

13-Dec-2021 By Jenni Spinner

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.

New inhaled SARS-CoV-2 antibody treatment set to enter clinical trials

13-Dec-2021 By Rachel Arthur

Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.

Former biopharmaceutical executives nabbed for insider trading

09-Dec-2021 By Jenni Spinner

The US Department of Justice has charged a former CFO and a former head of corporate communications for allegedly conducting an insider trading scheme.

Trial tech can help strengthen human connections in research: Within3

07-Dec-2021 By Jenni Spinner

According to a leader from the virtual engagement solutions company, gaps in trial communications can be improved with the intelligent use of technology.

Survey: research industry keen on DCT benefits, slow to adopt

07-Dec-2021 By Jenni Spinner

A survey on perceptions toward the decentralized clinical trial format, conducted by Climedo, shows the industry is aware of the benefits but faces barriers

Deloitte, PhRMA join forces on clinical trial diversity report

06-Dec-2021 By Jenni Spinner

The organizations have issued an in-depth look on issues impacting inclusivity, why change is needed, and potential solutions for increasing trial diversity.

Decentralized trials dramatically transforming clinical research: ICON

02-Dec-2021 By Jenni Spinner

An expert from the contract research organization discusses the impact decentralized trials have had on the industry, and how that transformation is likely to continue.

People on the Move: December 2021

02-Dec-2021 By Jenni Spinner

This month’s announcements of awards, expansions, name changes, hires, and other news includes items from CPhI, Almac Group, ICON, and other organizations.

AI-based blood analysis tool geared toward decentralized diagnostics

01-Dec-2021 By Jenni Spinner

With the release of its new Sight OLO artificial intelligence based blood analyzer, Sight Diagnostics hopes to offer DCTs reliable, easy-to-use testing.

Decentralized format can help elevate trial inclusivity: Science 37

01-Dec-2021 By Jenni Spinner

An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.

Automating safety processes can benefit DCTs: Pharmasol

01-Dec-2021 By Jenni Spinner

A leader from the pharmacovigilance solutions firm discusses the ins and outs managing safety documentation and offers advice on how to deal with them.

Navigating mobile research teams can help DCT success

01-Dec-2021 By Jenni Spinner

Leaders from IQVIA and its Q2 Solutions division offer advice on how to deal with mobile teams, home health providers, and other aspects of virtual trials.

Trial recruitment improving more rapidly in some populations than others: Phesi

30-Nov-2021 By Jenni Spinner

Patient data from the clinical solutions company indicates that gains in recruitment of Black participants is outpacing that of patients from other groups.

Mix-and-match COVID-19 vaccines: New trial to add to growing body of research

25-Nov-2021 By Rachel Arthur

A new clinical trial of heterologous – or ‘mix-and-match’ – combinations of COVID-19 vaccines is set to start in Pakistan: seeking to add to research on the effectiveness of such combinations.

Patient-centric eClinical tech can boost trials: Jeeva Informatics

23-Nov-2021 By Jenni Spinner

Leaders from the trial tech provider discuss how human-focused technology on eClinical platforms can tackle inefficiencies associated with traditional studies.

LMC Manna, IACT Health join in integrated research network

23-Nov-2021 By Jenni Spinner

The alliance is aimed at expanding service to pharmaceutical firms and other partners, and advancing treatment options for patients across North America.

Reify Health launches tool to gauge clinical trial diversity

22-Nov-2021 By Jenni Spinner

The StudyTeam Diversity Reporting feature is intended to aid sites and sponsors measure their efforts to reach patients from underrepresented communities.

Tech Innovations: November 2021

18-Nov-2021 By Jenni Spinner

This month’s launches, expanded facilities, partnerships, and other news includes items from Veeva, Hovione, Florence, Medidata, and other notable firms.

More sites and sponsors betting on decentralized format: Science 37

17-Nov-2021 By Jenni Spinner

According to data released by the company, the majority of study professionals plan to run agile or hybrid trials over the course of the next 12 months.

Gene-edited cell replacement therapy for diabetes set to enter the clinic

16-Nov-2021 By Rachel Arthur

CRISPR Therapeutics and ViaCyte, Inc. have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D)....

TFF completes dosing in Phase Ib clinical study for asthma drug

15-Nov-2021 By Jenni Spinner

The firm is investigating viability of voriconazole inhalation powder, intended to treat and prevent invasive pulmonary aspergillosis in asthma patients.

Biohaven wraps patient enrollment for ALS clinical trial arm

15-Nov-2021 By Jenni Spinner

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

Sanofi, Be the Match, and DiMe to weigh in on patient centricity

11-Nov-2021 By Jenni Spinner

During our November 17 webinar Patient-centric solutions, a group of professionals representing a range of perspectives will share ideas and innovations.

Clinical Ink snaps up digital CNS research technology firm

08-Nov-2021 By Jenni Spinner

The decentralized tech specialist has acquired Digital Artefacts, a research tech firm focused on cognitive, behavioral, and physiological data capture.

Industry veteran commits to improved patient solutions at CTMA

08-Nov-2021 By Jenni Spinner

After 30 years’ experience, including stints advising top pharma firms, the expert has joined a firm offering tech aimed at elevating patient ID and enrollment.

People on the Move: November 2021

04-Nov-2021 By Jenni Spinner

This month’s announcements of programs, names, appointments, hires, and other happenings includes items from Emmes, Science 37, Cerner and other companies.

Study coordinator pleads guilty to trial data falsification

01-Nov-2021 By Jenni Spinner

A former employee of Tellus Clinical Research in Miami has admitted to charges related to a conspiracy to falsify data on a list of clinical drug trials.

Gilead, Merck launch Phase II trial evaluating oral regimen for HIV-1 treatment

01-Nov-2021 By Jenni Spinner

The trial will evaluate a weekly regimen of islatravir and lnecapavir in HIV patients who are virologically suppressed while on antiretroviral therapies.

Digital transformation of clinical research accelerating rapidly: Veeva Systems

01-Nov-2021 By Jenni Spinner

The cloud software firm’s Digital Clinical Trials Survey Report reveals that the industry is adapting to challenges caused by COVID-19 and other factors.

Increased representation benefits cancer clinical trials: Science 37

28-Oct-2021 By Jenni Spinner

An expert from the decentralized study solutions company shares perspectives on the importance of inclusivity and solutions that could improve representation.

How can clinical research be truly patient centric?

28-Oct-2021 By Jenni Spinner

During OSP’s November 17 online event, a group of experts will offer insights, advice, and examples of solutions that put patients at the center of studies.

Survey: pandemic viewed as catalyst for positive change in trials

26-Oct-2021 By Jenni Spinner

According to a recent survey from Oracle Health Sciences, 97% of trial professionals say newly adopted approaches will stay in use as we move beyond COVID-19.